Área restringida

La información contenida en esta página está destinada a veterinarios y/o profesionales de salud animal con capacidad de prescripción y/o dispensación de medicamentos.

– Confirmo que soy veterinario o profesional de salud animal.

– Entiendo que la información disponible en esta página se refiere exclusivamente a productos y autorizaciones en España. La información en otros países, debo consultarla a través de los medios oficiales disponibles en el destino específico o con el Departamento de Exportación.

Vaccine

Print Friendly, PDF & Email

Agalax Tres

Inactivated vaccine against contagious agalactia as a suspension for injection

1. Warning

The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.

*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..

Quick product information

Active ingredient(s)Route of administrationWaiting timePackaging

– Inactivated mycoplasma agalactiae, strain N84

– Inactivated mycoplasma capricolum strain 27343

– Inactivated mycoplasma mycoides subsp. mycoides (LC) strain HH

Subcutaneous route

Zero days

50 mL (25 doses)

100 mL (50 doses)

250 mL (125 doses)

Country Availability

Bulgaria, Cyprus, Kuwait, Saudi Arabia, Spain.

If your country is not listed, please contact our export team.

Contactar

Active ingredient(s)

Inactivated mycoplasma agalactiae, strain N84 …………………………………………………….≥ 1/20*GI

Mycoplasma capricolum, strain 27343……………………………………………………………………… ≥ 1/20* GI

Mycoplasma mycoides subspecies mycoides (LC), strain HH……………………………………… ≥ 1/20* GI

GI* Antibody titre obtained by the growth inhibition technique after administration of a dose in lambs.

Indications

For active immunization of sheep and goats against contagious agalactia caused by Mycoplasma agalactiae to prevent infection and reduce clinical signs and/or lesions from the disease
Onset of immunity: one month after administration of the second dose
Duration of immunity: four months after administration of the second dose

Posology

2 mL/animal.

In healthy or undamaged herds, one application to all breeding stock, males and females and to all replacement animals from 2-3 months of age.

In healthy or undamaged herds, one application to all breeding stock, males and females and to all replacement animals from 2-3 months of age.

In general, revaccination is recommended every 4-6 months, depending on infection pressure.

Waiting time

Zero days.

Packaging

Containers with 100 mL (50 doses) and 250 mL (125 doses).

With veterinary prescription.

Registry no.: 2568 ESP